137 related articles for article (PubMed ID: 27462520)
1. Elevated level of nerve growth factor in the bladder pain syndrome/interstitial cystitis: a meta-analysis.
Chen W; Ye DY; Han DJ; Fu GQ; Zeng X; Lin W; Liang Y
Springerplus; 2016; 5(1):1072. PubMed ID: 27462520
[TBL] [Abstract][Full Text] [Related]
2. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
3. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
4. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
5. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
6. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
Jiang YH; Liu HT; Kuo HC
PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
[TBL] [Abstract][Full Text] [Related]
7. Sacral Neuromodulation for Refractory Bladder Pain Syndrome/Interstitial Cystitis: a Global Systematic Review and Meta-analysis.
Wang J; Chen Y; Chen J; Zhang G; Wu P
Sci Rep; 2017 Sep; 7(1):11031. PubMed ID: 28887515
[TBL] [Abstract][Full Text] [Related]
8. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.
Qu HC; Zhang W; Yan S; Liu YL; Wang P
PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532
[TBL] [Abstract][Full Text] [Related]
9. [Experimental evaluation of interaction of the nerve growth factor and mast cells in patients with interstitial cystitis/bladder pain syndrome].
Sholan RF
Urologiia; 2020 Apr; (2):31-34. PubMed ID: 32351060
[TBL] [Abstract][Full Text] [Related]
10. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
Jiang YH; Peng CH; Liu HT; Kuo HC
PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
[TBL] [Abstract][Full Text] [Related]
11. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
Sheng W; Zhang H; Ruth KH
Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
14. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome.
Liu BL; Yang F; Zhan HL; Feng ZY; Zhang ZG; Li WB; Zhou XF
Urol Int; 2014; 92(2):202-8. PubMed ID: 24458144
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
16. Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature.
Mahran A; Baaklini G; Hassani D; Abolella HA; Safwat AS; Neudecker M; Hijaz AK; Mahajan ST; Siegel SW; El-Nashar SA
Int Urogynecol J; 2019 Jul; 30(7):1023-1035. PubMed ID: 30874835
[TBL] [Abstract][Full Text] [Related]
17. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
Chuang YC; Chermansky C; Kashyap M; Tyagi P
Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play.
Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
Expert Rev Clin Pharmacol; 2018 May; 11(5):495-505. PubMed ID: 29575959
[TBL] [Abstract][Full Text] [Related]
19. Bladder pain syndrome/interstitial cystitis increase the risk of coronary heart disease.
Chen HM; Lin CC; Kang CS; Lee CT; Lin HC; Chung SD
Neurourol Urodyn; 2014 Jun; 33(5):511-5. PubMed ID: 23813657
[TBL] [Abstract][Full Text] [Related]
20. Bladder pain syndrome/interstitial cystitis is associated with anxiety disorder.
Chung KH; Liu SP; Lin HC; Chung SD
Neurourol Urodyn; 2014 Jan; 33(1):101-5. PubMed ID: 24038135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
